May 15, 2025
The makers of gastrointestinal drug Trulance have resolved their patent lawsuit, which sought to block several Mylan generic drugs from competing with the drug, in a confidential settlement agreement, according to a West Virginia federal court filing.
March 30, 2023
West Virginia's top judge on Thursday rejected arguments from the makers of gastrointestinal drug Trulance to hand the companies a win in their effort to assert patents to block several Mylan generics from competing with the drug.
March 10, 2022
A New Jersey federal judge on Tuesday dismissed several Mylan entities from a patent suit relating to their purported plans to market generic versions of gastrointestinal drug Trulance, while also tossing a number of patent claims and sending the remainder to West Virginia federal court.